Form 4: Rocket Pharmaceuticals General Counsel Sells Shares to Cover Tax Obligations

Rocket Pharmaceuticals' General Counsel, Martin Wilson, sold 1,175 shares of common stock to cover tax obligations related to the vesting of Restricted Stock Units.

Summary

• Martin Wilson, the General Counsel of Rocket Pharmaceuticals, sold 1,175 shares of common stock on November 21, 2024.
• The sale was executed at a price of $13.054 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Mr. Wilson directly owns 63,560 shares of Rocket Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes and does not indicate any positive or negative sentiment towards the company's performance.

Industry Context

This is a routine transaction for company insiders to manage their tax obligations related to equity compensation. It is common for executives to sell shares after vesting to cover taxes.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• Many companies use Restricted Stock Units (RSUs) as part of their compensation packages, which often lead to similar transactions when the RSUs vest.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale for tax purposes.

Key Dates

Keywords

Rocket Pharmaceuticals, insider trading, Form 4, stock sale, Martin Wilson, General Counsel, tax obligations, restricted stock units, RCKT